Explore our flagship, batch-tested dietary supplements and personal care formulas manufactured in our state-of-the-art cGMP facility.
In the modern health and wellness ecosystem, securing a reliable, scientifically robust OEM/ODM supplements manufacturer is no longer merely an operational procurement decision—it is a core strategic lever for long-term brand equity and market survival. The global contract manufacturing industry has transitioned from basic toll blending (simple dry mixing of off-the-shelf ingredients) toward sophisticated, bio-engineered Contract Development and Manufacturing Organization (CDMO) capabilities. Today’s consumer demands rapid onset of action, clean label excipients, proven clinical efficacy, and absolute transparency regarding raw material provenance.
ProTech Health Sciences operates at the forefront of this industrial transformation. With over two decades of dedicated R&D infrastructure and high-capacity manufacturing lines, we bridge the complex gap between raw biochemical scientific research and commercially scalable, shelf-ready consumer products. Whether your business requires advanced micro-encapsulated sport nutrition powders, chewable vitamin gummies with stabilized active thermal matrices, or targeted botanical extracts like Astragaloside IV, our manufacturing architecture guarantees strict batch-to-batch consistency and international regulatory compliance.
Choosing an OEM/ODM supplement partner requires rigorous due diligence across multiple technical parameters. ProTech’s manufacturing ecosystem is built around four core enterprise pillars designed to minimize regulatory risk and optimize bio-accessibility for finished products:
Our processing cleanrooms adhere strictly to ISO Class 8 (100,000-level purification) standards. We maintain continuous positive differential air pressure, HEPA filtration, and automated humidity controls (under 40% RH for hygroscopic powders) to prevent microbial contamination and ingredient degradation.
Every incoming raw material and outgoing finished batch undergoes quantitative testing via High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Mass Spectrometry (GC-MS), and Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metal safety (Pb, Cd, Hg, As).
Our team of food scientists, biochemists, and galenic formulation specialists can develop custom stable prototypes within 7 working days. We solve complex stability issues such as ingredient cross-reactivity, taste masking, and oxidation prevention.
To capture distinct market segments—from elite sports performance to clinical wellness and pet healthcare—brand owners must diversify their product delivery formats. ProTech provides a versatile range of contract manufacturing formats tailored to specific physiological delivery requirements:
Powder supplements demand superior solubility, uniform particle distribution, and flawless taste profiles. Utilizing advanced 3D cone blending and fluid-bed granulation technology, we produce high-density plant-based proteins, micronized creatine monohydrate (200 mesh for immediate dispersion), and complex amino acid energy matrices. Our flavor chemists employ micro-encapsulated aroma systems that effectively mask bitter botanical actives without relying on high-glycemic sugars.
Our high-speed rotary tablet presses handle multi-stage compaction for single-entity actives (such as 60-count Vegan Taurine Tablets) as well as complex multi-vitamin, mineral, and botanical matrices. We offer aqueous film coating, enteric coating for targeted intestinal release, and effervescent tablet manufacturing engineered with moisture-controlled packaging to prevent premature gas release.
Functional gummies represent one of the fastest-growing categories in direct-to-consumer healthcare. ProTech utilizes continuous-cooker starchless depositing lines to create precise dosage gummies in various shapes (bears, hearts, stars, domes). We specialize in pectin-based (vegan-friendly) formulations that exhibit elevated thermal stability (up to 45°C) to withstand tropical export supply chains without melting or clump formation.
Offering Gelatin, HPMC (Vegetarian), and Pullulan capsule shells in sizes 000 through 4. We specialize in dual-phase liquid-filled capsules and beadlet-in-capsule technology, enabling sustained release of incompatible bioactive compounds within a single dosage unit.
Beyond human oral supplements, ProTech operates dedicated production lines for salon-grade hair repair treatments, sulfate-free shampoos, bioactive facial serums, and chelated trace-mineral premixes for multi-species animal nutrition. This holistic operational scope makes ProTech an end-to-end partner for lifestyle and wellness brand portfolios.
The nutraceutical supply chain is experiencing dramatic structural shifts driven by geopolitical changes, consumer sustainability demands, and regulatory harmonization across global trade blocs. Brand managers and procurement teams must align with an OEM partner capable of navigating these emerging macro trends:
Standard raw powders are increasingly being replaced by liposomal encapsulation, phytosome complexes, and self-emulsifying drug delivery systems (SEDDS). These technologies significantly enhance cellular uptake of hydrophobic actives like Curcumin, CoQ10, and Astragaloside IV.
Global regulatory bodies and consumers are phasing out synthetic flow agents like Titanium Dioxide, Magnesium Stearate, and Silicon Dioxide. Forward-thinking OEMs are transitioning exclusively to organic rice extract, bamboo silica, and sunflower lecithin emulsifiers.
Supply chain transparency now requires complete origin verification via DNA barcoding and mass spectrometry. Procurement managers are prioritizing upcycled botanical side-streams (e.g., fruit pomace polyphenol extracts) to meet ESG sustainability mandates.
Cross-border e-commerce demands formulas pre-cleared for multiple jurisdictions simultaneously (such as ASEAN cosmetic/supplement directives, EU EFSA novelty rules, and US FDA NDI notifications). Unified regulatory documentation accelerates global scaling.
Before committing to a contract manufacturing contract, procurement officers should conduct a structured supplier facility audit. ProTech provides complete transparency across all key audit vectors:
Detailed answers regarding MOQ thresholds, R&D timelines, quality control protocols, and custom OEM manufacturing workflows.
Our standard production MOQs depend on the selected dosage form and packaging configuration. Generally, encapsulated products start at 300,000 capsules (or approx. 3,000–5,000 retail bottles), tableting runs start at 100,000 units, and custom gummy batches begin at 500 kg per flavor/formula. Powder sachet and bulk powder blending MOQs typically start at 500 kg to ensure optimal batch homogeneity in our industrial blenders. Flexible trial runs are available for emerging enterprise partners upon consultation.
We utilize accelerated degradation modeling (storing samples at elevated temperature and humidity conditions of 40°C / 75% RH) alongside real-time stability testing. To account for natural bioactive decay over a 24-to-36-month shelf life, our galenic formulation scientists incorporate precise, safe "overages" based on empirical stability kinetics. Additionally, micro-encapsulation and nitrogen-flushed primary packaging are implemented to shield light- and oxygen-sensitive actives from degradation.
Yes. ProTech operates accredited production lines compliant with global Halal standards (certified by recognized Islamic bodies), ISO 22000, and cGMP. We offer 100% plant-based HPMC and Pullulan capsule shells, pectin-based gummy matrices, and organic botanical extracts. All raw materials undergo rigorous cross-contamination screening to ensure zero animal DNA or non-compliant processing aids exist in specialized production runs.
For standard formulations utilizing our repository of 500+ pre-validated ingredients, benchtop pilot samples can be delivered for client evaluation within 7 working days. Once the sample and packaging artwork are approved, full-scale commercial manufacturing, quality testing, and Certificate of Analysis (COA) release generally require 30 to 45 calendar days. Complex custom synthetic or novel botanical formulations requiring extended stability validation may add 2 to 3 weeks to the initial launch phase.
We offer fully transparent contract models. For custom ODM formulations developed under a proprietary client brief, full IP ownership rights can be assigned to the brand owner upon contract fulfillment and volume agreement commitments. Alternatively, brands seeking rapid market entry can license our pre-existing, clinically-backed stock formulations under private label terms, significantly reducing upfront development costs.
Connect directly with our senior formulation scientists and regulatory team today. Receive a custom quote, technical feasibility report, and complimentary prototype sampling within 7 working days.
Send an Inquiry